secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0000105770-24-000071
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma CTO Silji Abraham resigns effective Dec 31, 2024
------------------------------------------------------------

- Silji Abraham, SVP & Chief Technology Officer, notified resignation on Oct 1, 2024.
- Departure effective December 31, 2024; he leaves to pursue other interests.
- Company states departure is not due to any disagreement on operations, policies, or practices.
- No additional compensation or severance will be provided in connection with the resignation.
- Transition plan involves working with Abraham and his leadership team to ensure smooth handover.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000071/0000105770-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000071/wst-20241001.htm
  HTML page:      https://secwatch.observer/filing/0000105770-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer